Desensitisation of the youngest patient with Pompe disease in response to alglucosidase alfa

Allergol Immunopathol (Madr). 2014 Jul-Aug;42(4):372-5. doi: 10.1016/j.aller.2013.02.012. Epub 2013 Jun 14.

Authors

I H E Karagol¹, A Bakirtas², O Yilmaz², E Topal², A Kucukcongar³, F S Ezgu³, M S Demirsoy², I Turktas²

Affiliations

¹ Department of Pediatric Asthma and Allergy, Gazi University Faculty of Medicine, Ankara, Turkey. Electronic address: [email protected].
² Department of Pediatric Asthma and Allergy, Gazi University Faculty of Medicine, Ankara, Turkey.
³ Department of Pediatric Metabolism, Gazi University Faculty of Medicine, Ankara, Turkey.

PMID: 23769736
DOI: 10.1016/j.aller.2013.02.012

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Desensitization, Immunologic / methods*
Drug Hypersensitivity / etiology
Drug Hypersensitivity / prevention & control*
Female
Glycogen Storage Disease Type II / drug therapy*
Humans
Infant
Recombinant Proteins / therapeutic use
alpha-Glucosidases / therapeutic use*

Substances

Recombinant Proteins
GAA protein, human
alpha-Glucosidases